To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
Why Every Pharmacist Should Care About the CVS/Aetna Deal
Even if it doesn't happen, the deal says a lot about the future of pharmacy.
Read more
 
ADVERTISEMENT
 
FDA: Febuxostat Linked with Increased Risk of Cardiac Death
Compared to allopurinol, febuxostat has an increased risk of heart-related deaths.
Read more
 
ADVERTISEMENT
 
Baxter Issues Recall of Nexterone Injection
The affected lots could contain particulate matter.
Read more
 
Job Market Shifting for Pharmacy School Grads
Where are today's grads going (and why are there fewer of them)?
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.